When co-cultured with iPSC CD276-targeted CAR-NK cells at the same dose from day 1 to day 5 (Figure 2A), the CD276-expressing ESCC PSO significantly disintegrated and suspended, while the CD276-negative NC PSO persisted and grew at the same time. This evidence concerns the gene CD276 and esophageal squamous cell carcinoma.